Translation of oncology multidisciplinary team meeting (MDM) recommendations into clinical practice

Vinod, Shalini K.; Wellege, Nisali T.; Kim, Sara; Duggan, Kirsten J.; Ibrahim, Mirette; Shafiq, Jesmin

doi:10.1186/s12913-021-06511-3

BMC Health Services Research

Table 5 Comparison of findings with published literature

From: Translation of oncology multidisciplinary team meeting (MDM) recommendations into clinical practice

Author & Country	Study type	Study period	n	Number of MDM decisions	Concordance Rate %- Patients	Concordance Rate % - Decisions
Neuro-oncology
Hollunder et al., Germany [20]	Retrospective	2014–2016	1406	2176		64-80^a
Lutterbach et al., Germany [27]	Retrospective	1998–2003	500	–	91	–
Current Study	Retrospective	2017	73	–	90 – 97^a
Breast
English et al., England [31]	Prospective	2007	210	289	_	93
Pattanasri et al., Australia [32]	Retrospective	2010 & 2014	375	–	82	–
Rajan et al., England [30]	Retrospective	2009–2011	705	3230	_	92
Samarasinghe et al., Australia [33]	Retrospective	2011–2016	925	2599	92	96
Current Study	Retrospective	2017	126	–	87 – 97^a
Colorectal
Au-Yeung et al., Australia [13]	Retrospective	2010	37	–	89
Alfarhan et al., Saudi Arabia [5]	Retrospective	2013	104^b	158	–	87
Munro et al., Scotland [17]	Retrospective	2006–2007	513	–	80	–
Wood et al., England [28]	Prospective	2005–2006	157	201	_	90
Current Study	Retrospective	2017	79	–	75 – 89^a
Upper Gastrointestinal
Au-Yeung et al., Australia [13]	Retrospective	2010	37	–	92
Blazeby et al., England [21]	Prospective	2003–2004	273	271	–	85
Bumm et al., Germany [22]	Retrospective	1999–2006	730	807		96
Goolam-Hossen et al., England [23]	Retrospective	2006	363	–	81	–
Gashin et al., USA [39]	Retrospective	2009–2010	137^c	419	34	65
Current study	Retrospective	2017	108	–	80 – 94^a
Genitourinary
Au-Yeung et al., Australia [13]	Retrospective	2010	86	–	99
Current Study	Retrospective	2017	53	–	68–89
Gynaecological
Current Study	Retrospective		67	–	78 – 97^a
Head and Neck
Brunner et al., Australia [6]	Prospective	2011–2012	158	–	84	–
Hollunder et al., Germany [20]	Retrospective	2014–2016	812	1319		70-82^a
Current Study	Retrospective	2017	84		80 – 92^a
Lung
Leo et al., France [25]	Prospective	2003–2004	344	–	96	–
Loh et al., New Zealand [26]	Retrospective	2009	110	–	71	–
Osarogiagbon et al., USA [24]	Retrospective	2006–2009	376	454	63	62
Ung et al., Australia [7]	Prospective	2011	65	–	72	–
Current Study	Retrospective	2017	142	–	73 – 85^a	–
Skin
Caudron et al., France [10]	Retrospective	2006–2007	228	309	–	80 – 88^a
Current Study	Retrospective	2017	39	–	82 – 95^a
Multiple Tumour Sites
De leso et al., England [19]	Retrospective	2010	551^d	–	91	–
Hollunder et al., Germany [20]	Retrospective	2014–2016	2450^e	3815		66-80^a
Schmidt et al., USA [4]	Prospective	2010–2012	587^f	843	98^g	–
Current Study	Retrospective	2017	771		79 – 92^a	–

^aLowest figure is “fully concordant’ and highest figure is ‘fully and partially concordant’
^bIncluded all GI cancers but majority (63%) colorectal
^cOnly included hepatocellular carcinoma
^dIncluded 14 adult cancer MDMs
^eIncluded neurooncology, head and neck cancers and musculoskeletal tumours
^fIncluded lung and oesophagus cancers
^gConcordance data only available in 52% of patients treated at single institution

Back to article page

ISSN: 1472-6963

Contact us

General enquiries: journalsubmissions@springernature.com